CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience
{{output}}
Background: Aromatase inhibitors (AIs) are associated with musculoskeletal pain in one third (20-47%) of breast cancer patients. Recently, CDK4/6 inhibitors have emerged as a new therapeutic approach in hormone receptor (HR)-posi... ...
